MEA Antiviral Drugs Market - Industry Trends and Forecast to 2030
Middle East and Africa antiviral drugs market is expected to reach USD 2,225.82 million by 2030 from USD 1,771.23 million in 2022, growing with a CAGR of 2.9% during the forecast period from 2023 to 2030.
Market Segmentation:
Middle East and Africa Antiviral Drugs Market, By Indication (Influenza, Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Respiratory Syncytial Virus (RSV), Herpes Simplex Virus, Human Cytomegalovirus (HCMV), Varicella-Zoster Virus (VZV), Hepatitis B Virus (HBV), Coronavirus Infection, and Others), Patient Type (Child, Adult, and Geriatric), Products (Oral, Topical, and Parenteral), Drug Type (Generic and Branded), End User (Hospitals, Clinics, Home Healthcare, Specialty Centers, Ambulatory Centers, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030.
Overview of Middle East and Africa Antiviral Drugs Market Dynamics:
Driver
• Rising prevalence of viral infections
Restrain
• High cost of antiviral drugs
Opportunity
• Increasing collaboration and partnership among key players
Market Players:
Some of the key market players operating in the Middle East and Africa antiviral drugs market are listed below:
• Gilead Sciences, Inc.
• F. Hoffmann-La Roche Ltd
• GLAXOSMITHKLINE PLC
• Abbvie
• Merck & Co., Inc.
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Cipla Inc.
• Aurobindo Pharma
• Dr. Reddy’s Laboratories Ltd.
• Zydus Pharmaceuticals, Inc.
• Mylan Pharmaceuticals ULC
• Teva Pharmaceuticals USA, Inc.
• EMERGENT
• Sun Pharmaceutical Industries Ltd.
• Avet Pharmaceuticals Inc.
• Pfizer Inc.
• SIGA Technologies
• NAVINTA LLC.
• Macleods Pharmaceuticals Ltd.
• BioCryst Pharmaceuticals, Inc
• Hetero
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
- 1 Introduction 119
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Middle East And Africa Antiviral Drugs Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation 127
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market Testing Type Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary 139
- 4 Premium Insights 142
- 4.1 Porter’s Five Forces
- 4.2 Pestel Analysis
- 5 Epidemiology 145
- 6 Pipeline Analysis For Middle East And Africa Antiviral Drugs Market 146
- 7 Regulatory Framework 147
- 8 Market Overview 149
- 8.1 Drivers
- 8.1.1 Rising Prevalence Of Viral Infections
- 8.1.2 Advancements In New Antiviral Drug Development
- 8.1.3 Growing Demand For Combination Therapies
- 8.1.4 Increasing Government Funding And R&D Activities
- 8.2 Restrains
- 8.2.1 High Cost Of Antiviral Drugs
- 8.2.2 Emergence Of Drug-resistant Strains Of Viruses
- 8.3 Opportunities
- 8.3.1 Increasing Collaboration And Partnership Among Key Players
- 8.3.2 Rising Novel Drug Delivery Systems
- 8.3.3 Development Of Personalized Medicines
- 8.4 Challenges
- 8.4.1 Patent Expiration Of Antiviral Drugs
- 8.4.2 Demand For Alternative Medicines
- 9 Middle East And Africa Antiviral Drugs Market, By Indication 159
- 9.1 Overview
- 9.2 Influenza
- 9.2.1 Neuraminidase Inhibitors
- 9.2.1.1 Oseltamivir
- 9.2.1.2 Zanamivir
- 9.2.1.3 Peramivir
- 9.2.1.4 Laninamivir
- 9.2.2 M2 Inhibitors
- 9.2.2.1 Rimantadine
- 9.2.2.2 Others
- 9.2.3 Rna Polymerase Inhibitors
- 9.2.3.1 Favipiravir
- 9.2.3.2 Baloxavir Marboxil
- 9.3 Human Immunodeficiency Virus (Hiv)
- 9.3.1 Reverse Transcriptase Inhibitors
- 9.3.1.1 Nucleoside (Nrtis)
- 9.3.1.1.1 Lamivudine
- 9.3.1.1.2 Abacavir
- 9.3.1.1.3 Didanosine
- 9.3.1.1.4 Others
- 9.3.1.2 Nonnucleoside (Nnrtis)
- 9.3.1.2.1 Efavirenz
- 9.3.1.2.2 Nevirapine
- 9.3.1.2.3 Delavirdine
- 9.3.1.2.4 Others
- 9.3.1.3 Integrase
- 9.3.1.3.1 Dolutegravir
- 9.3.1.3.2 Elvitegravir
- 9.3.1.3.3 Raltegravir
- 9.3.1.3.4 Bictegravir
- 9.3.1.4 Nucleotide
- 9.3.1.4.1 Tenofovir
- 9.3.1.4.2 Others
- 9.3.1.5 Interferons
- 9.3.1.5.1 Alpha
- 9.3.1.5.2 Beta
- 9.3.1.5.3 Gamma
- 9.3.1.6 Gp41
- 9.3.1.6.1 Enfuvirtide
- 9.3.1.6.2 Others
- 9.3.2 Protease
- 9.3.2.1 Atazanavir
- 9.3.2.2 Darunavir
- 9.3.2.3 Lopinavir
- 9.3.2.4 Ritonavir
- 9.3.2.5 Saquinavir
- 9.3.2.6 Indinavir
- 9.3.2.7 Nelfinavir
- 9.3.2.8 Tipranavir
- 9.3.2.9 Amprenavir
- 9.4 Hepatitis C Virus
- 9.4.1 Ns5b Polymerase
- 9.4.1.1 Sofosbuvir
- 9.4.1.2 Dasabuvir
- 9.4.2 Ns3/4a Protease
- 9.4.2.1 Danoprevir
- 9.4.2.2 Glecaprevir
- 9.4.2.3 Grazoprevir
- 9.4.2.4 Paritaprevir
- 9.4.2.5 Simeprevir
- 9.4.3 Ns5a Phosphoprotein
- 9.4.3.1 Ledipasvir
- 9.4.3.2 Velpatasvir
- 9.4.3.3 Ombitasvir
- 9.4.3.4 Elbasvir
- 9.4.3.5 Daclatasvir
- 9.4.3.6 Pibrentasvir
- 9.4.4 Neuraminidase
- 9.4.4.1 Oseltamivir
- 9.4.4.2 Zanamivir
- 9.4.4.3 Peramivir
- 9.4.4.4 Laninamivir
- 9.4.5 Rna Polymerase
- 9.4.5.1 Baloxavir Marboxil
- 9.4.5.2 Favipiravir
- 9.4.6 Matrix Protein 2
- 9.4.6.1 Rimatidine
- 9.4.6.2 Favipiravir
- 9.5 Herpes Simplex Virus
- 9.5.1 Dna Polymerase Ul30
- 9.5.1.1 Aciclovir
- 9.5.1.2 Famciclovir
- 9.5.1.3 Valaciclovir
- 9.5.1.4 Penciclovir Trifluridine
- 9.5.1.5 Brivudine
- 9.5.1.6 Foscarnet
- 9.5.1.7 Idoxuridine
- 9.5.2 Envelope Proteins
- 9.5.2.1 Docosanol
- 9.5.2.2 Others
- 9.6 Human Cytomegalovirus (Hcmv)
- 9.6.1 Ganciclovir
- 9.6.2 Valganciclovir
- 9.6.3 Cidofovir
- 9.6.4 Foscarnet
- 9.6.5 Fomivirsen
- 9.7 Varicella-zoster Virus (Vzv)
- 9.7.1 Valaciclovir
- 9.7.2 Famciclovir
- 9.7.3 Aciclovir
- 9.7.4 Vidarabine
- 9.7.5 Brivudine
- 9.8 Hepatitis B Virus
- 9.8.1 Entecavir
- 9.8.2 Tenofovir
- 9.8.3 Telbivudine
- 9.8.4 Tenofovir Alafenamide
- 9.8.5 Others
- 9.9 Respiratory Syncytial Virus
- 9.9.1 Rna Polymerase
- 9.9.1.1 Ribavirin
- 9.9.1.2 Others
- 9.9.2 Fusion Glycoprotein
- 9.9.2.1 Palivizumab
- 9.9.2.2 Others
- 9.10 Coronavirus Infection
- 9.11 Others
- 10 Middle East And Africa Antiviral Drugs Market, By Patient Type 190
- 10.1 Overview
- 10.2 Geriatric
- 10.2.1 Male
- 10.2.2 Female
- 10.3 Child
- 10.3.1 Male
- 10.3.2 Female
- 10.4 Adult
- 10.4.1 Male
- 10.4.2 Female
- 11 Middle East And Africa Antiviral Drugs Market, By Products 198
- 11.1 Overview
- 11.2 Oral
- 11.2.1 Solid
- 11.2.1.1 Tablets
- 11.2.1.2 Capsules
- 11.2.1.3 Others
- 11.2.2 Semisolid
- 11.2.2.1 Gels
- 11.2.2.2 Emulsions
- 11.2.2.3 Elixirs
- 11.2.2.4 Others
- 11.2.3 Liquid
- 11.2.3.1 Solutions
- 11.2.3.2 Syrups
- 11.2.3.3 Others
- 11.3 Topical
- 11.3.1 Semi-solid
- 11.3.1.1 Cream
- 11.3.1.2 Ointment
- 11.3.1.3 Gels
- 11.3.1.4 Others
- 11.3.2 Liquid
- 11.3.2.1 Solutions
- 11.3.2.2 Suspensions
- 11.3.3 Solid
- 11.3.3.1 Powders
- 11.3.3.2 Suppositories
- 11.3.3.3 Enema
- 11.3.3.4 Others
- 11.4 Parenteral
- 11.4.1 Conventional Drug Delivery Formualtions
- 11.4.1.1 Solutions
- 11.4.1.2 Reconstituted/Lyophilized
- 11.4.1.3 Suspensions
- 11.4.1.4 Emulsions
- 11.4.1.5 Others
- 11.4.2 Novel Drug Delivery Formulations
- 11.4.3 Colloidal Dispersions
- 11.4.4 Long Acting Injection Formulation
- 12 Middle East And Africa Antiviral Drugs Market, By Drug Type 211
- 12.1 Overview
- 12.2 Generic
- 12.3 Branded
- 13 Middle East And Africa Antiviral Drugs Market, By End User 216
- 13.1 Overview
- 13.2 Hospital
- 13.3 Specialty Centers
- 13.4 Ambulatory Centres
- 13.5 Clinics
- 13.6 Home Healthcare
- 13.7 Others
- 14 Middle East And Africa Antiviral Drugs Market, By Distribution Channel 223
- 14.1 Overview
- 14.2 Hospital Pharmacy
- 14.3 Retail Pharmacy
- 14.4 Online Pharmacy
- 15 Middle East And Africa Antiviral Drugs Market, By Region 229
- 15.1 Middle East And Africa
- 15.1.1 South Africa
- 15.1.2 Saudi Arabia
- 15.1.3 Uae
- 15.1.4 Egypt
- 15.1.5 Kuwait
- 15.1.6 Israel
- 15.1.7 Rest Of Middle East And Africa
- 16 Middle East And Africa Antiviral Drugs Market: Company Landscape 334
- 16.1 Company Share Analysis: Middle East And Africa
- 17 Swot Analysis 335
- 18 Company Profile 336
- 18.1 Gilead Sciences, Inc. (2022)
- 18.1.1 Company Snapshot
- 18.1.2 Revenue Analysis
- 18.1.3 Company Share Analysis
- 18.1.4 Product Portfolio
- 18.1.5 Recent Development
- List Of Tables
- Table 1 Middle East And Africa Antiviral Drugs Market, By Indication, 2021- 2030 (Usd Million)
- Table 2 Middle East And Africa Influenza In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 3 Middle East And Africa Influenza In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 4 Middle East And Africa Neuraminidase Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 5 Middle East And Africa M2 Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 6 Middle East And Africa M2 Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 7 Middle East And Africa Human Immunodeficiency Virus (Hiv) In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 8 Middle East And Africa Human Immunodeficiency Virus (Hiv) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 9 Middle East And Africa Reverse Transcriptase Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 10 Middle East And Africa Nucleoside (Nrtis) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 11 Middle East And Africa Nonnucleoside (Nnrtis) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 12 Middle East And Africa Integrase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 13 Middle East And Africa Nucleotide In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 14 Middle East And Africa Interferons In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 15 Middle East And Africa Gp41 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 16 Middle East And Africa Protease In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 17 Middle East And Africa Hepatitis C Virus In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 18 Middle East And Africa Hepatitis C Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 19 Middle East And Africa Ns5b Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 20 Middle East And Africa Ns3/4a Protease In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 21 Middle East And Africa Ns5a Phosphoprotein In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 22 Middle East And Africa Neuraminidase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 23 Middle East And Africa Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 24 Middle East And Africa Matrix Protein 2 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 25 Middle East And Africa Herpes Simplex Virus In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 26 Middle East And Africa Herpes Simplex Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 27 Middle East And Africa Dna Polymerase Ul30 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 28 Middle East And Africa Envelope Proteins In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 29 Middle East And Africa Human Cytomegalovirus (Hcmv) In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 30 Middle East And Africa Human Cytomegalovirus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 31 Middle East And Africa Varicella-zoster Virus (Vzv) In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 32 Middle East And Africa Dna Polymerase Adefovir In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 33 Middle East And Africa Hepatitis B Virus In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 34 Middle East And Africa Dna Polymerase Adefovir In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 35 Middle East And Africa Respiratory Syncytial Virus In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 36 Middle East And Africa Respiratory Syncytical Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 37 Middle East And Africa Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 38 Middle East And Africa Fusion Glycoprotein In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 39 Middle East And Africa Coronavirus Infection In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 40 Middle East And Africa Others In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 41 Middle East And Africa Antiviral Drugs Market, By Patient Type, 2021- 2030 (Usd Million)
- Table 42 Middle East And Africa Geriatric In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 43 Middle East And Africa Geriatric In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 44 Middle East And Africa Child In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 45 Middle East And Africa Child In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 46 Middle East And Africa Adult In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 47 Middle East And Africa Adult In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 48 Middle East And Africa Antiviral Drugs Market, By Product, 2021- 2030 (Usd Million)
- Table 49 Middle East And Africa Oral In Antiviral Drugs Market, By Region, 2021-2030 (Usd Million)
- Table 50 Middle East And Africa Oral In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 51 Middle East And Africa Solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 52 Middle East And Africa Semi-solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 53 Middle East And Africa Liquid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 54 Middle East And Africa Topical In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 55 Middle East And Africa Topical In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 56 Middle East And Africa Semi-solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 57 Middle East And Africa Liquid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 58 Middle East And Africa Solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 59 Middle East And Africa Parenteral In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 60 Middle East And Africa Parenteral In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 61 Middle East And Africa Conventional Drug Delivery Formulations In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 62 Middle East And Africa Novel Drug Delivery Formulations In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 63 Middle East And Africa Antiviral Drugs Market, By Drug Type, 2021- 2030 (Usd Million)
- Table 64 Middle East And Africa Antiviral Drugs Market, By End User, 2021- 2030 (Usd Million)
- Table 65 Middle East And Africa Antiviral Drugs Market, By Distribution Channel, 2021- 2030 (Usd Million)
- Table 66 Middle East And Africa Antiviral Drugs Market, By Country, 2021-2030 (Usd Million)
- Table 67 Middle East And Africa Antiviral Drugs Market, By Indication, 2021-2030 (Usd Million)
- Table 68 Middle East And Africa Influenza In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 69 Middle East And Africa Neuraminidase Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 70 Middle East And Africa M2 Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 71 Middle East And Africa Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 72 Middle East And Africa Human Immunodeficiency Virus (Hiv) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 73 Middle East And Africa Reverse Transcriptase Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 74 Middle East And Africa Nucleoside (Nrtis) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 75 Middle East And Africa Nonnucleoside (Nnrtis) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 76 Middle East And Africa Integrase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 77 Middle East And Africa Nucleotide In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 78 Middle East And Africa Interferons In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 79 Middle East And Africa Gp41 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 80 Middle East And Africa Protease In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 81 Middle East And Africa Hepatitis C Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 82 Middle East And Africa Ns5b Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 83 Middle East And Africa Ns3/4a Protease In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 84 Middle East And Africa Ns5a Phosphoprotein In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 85 Middle East And Africa Neuraminidase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 86 Middle East And Africa Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 87 Middle East And Africa Matrix Protein 2 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 88 Middle East And Africa Herpes Simplex Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 89 Middle East And Africa Dna Polymerase Ul30 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 90 Middle East And Africa Envelope Proteins In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 91 Middle East And Africa Human Cytomegalovirus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 92 Middle East And Africa Varicella-zoster Virus (Vzv) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 93 Middle East And Africa Dna Polymerase Adefovir In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 94 Middle East And Africa Respiratory Syncytical Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 95 Middle East And Africa Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 96 Middle East And Africa Fusion Glycoprotein In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 97 Middle East And Africa Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 98 Middle East And Africa Geriatric In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 99 Middle East And Africa Child In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 100 Middle East And Africa Adult In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 101 Middle East And Africa Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 102 Middle East And Africa Oral In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 103 Middle East And Africa Solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 104 Middle East And Africa Semi-solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 105 Middle East And Africa Liquid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 106 Middle East And Africa Topical In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 107 Middle East And Africa Semi-solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 108 Middle East And Africa Liquid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 109 Middle East And Africa Solid In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 110 Middle East And Africa Parenteral In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 111 Middle East And Africa Conventional Drug Delivery Formulations In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 112 Middle East And Africa Novel Drug Delivery Formulations In Antiviral Drugs Market, By Products, 2021-2030 (Usd Million)
- Table 113 Middle East And Africa Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 114 Middle East And Africa Antiviral Drugs Market, By End User, 2021-2030 (Usd Million)
- Table 115 Middle East And Africa Antiviral Drugs Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 116 South Africa Antiviral Drugs Market, By Indication, 2021-2030 (Usd Million)
- Table 117 South Africa Influenza In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 118 South Africa Neuraminidase Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 119 South Africa M2 Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 120 South Africa Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 121 South Africa Human Immunodeficiency Virus (Hiv) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 122 South Africa Reverse Transcriptase Inhibitors In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 123 South Africa Nucleoside (Nrtis) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 124 South Africa Nonnucleoside (Nnrtis) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 125 South Africa Integrase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 126 South Africa Nucleotide In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 127 South Africa Interferons In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 128 South Africa Gp41 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 129 South Africa Protease In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 130 South Africa Hepatitis C Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 131 South Africa Ns5b Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 132 South Africa Ns3/4a Protease In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 133 South Africa Ns5a Phosphoprotein In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 134 South Africa Neuraminidase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 135 South Africa Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 136 South Africa Matrix Protein 2 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 137 South Africa Herpes Simplex Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 138 South Africa Dna Polymerase Ul30 In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 139 South Africa Envelope Proteins In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 140 South Africa Human Cytomegalovirus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 141 South Africa Varicella-zoster Virus (Vzv) In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 142 South Africa Dna Polymerase Adefovir In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 143 South Africa Respiratory Syncytical Virus In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 144 South Africa Rna Polymerase In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 145 South Africa Fusion Glycoprotein In Antiviral Drugs Market, By Drug Type, 2021-2030 (Usd Million)
- Table 146 South Africa Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 147 South Africa Geriatric In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 148 South Africa Child In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- Table 149 South Africa Adult In Antiviral Drugs Market, By Patient Type, 2021-2030 (Usd Million)
- List Of Figures
- Figure 1 Middle East And Africa Antiviral Drugs: Segmentation
- Figure 2 Middle East And Africa Antiviral Drugs Market: Data Triangulation
- Figure 3 Middle East And Africa Antiviral Drugs Market: Droc Analysis
- Figure 4 Middle East And Africa Antiviral Drugs Market: Middle East And Africa Vs Regional Market Analysis
- Figure 5 Middle East And Africa Antiviral Drugs Market: Company Research Analysis
- Figure 6 Middle East And Africa Antiviral Drugs Market: Interview Demographics
- Figure 7 Middle East And Africa Antiviral Drugs Market: Dbmr Market Position Grid
- Figure 8 Middle East And Africa Antiviral Drugs Market: Market Testing Type Coverage Grid
- Figure 9 Middle East And Africa Antiviral Drugs Market: Vendor Share Analysis
- Figure 10 Middle East And Africa Antiviral Drugs Market: Segmentation
- Figure 11 The Rising Prevalence Of Viral Infections Is Expected To Drive The Middle East And Africa Antiviral Drugs Market In The Forecast Period
- Figure 12 The Influenza Segment Is Expected To Account For The Largest Share Of The Middle East And Africa Antiviral Drugs Market In 2023 & 2030
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Middle East And Africa Antiviral Drugs Market
- Figure 14 Middle East And Africa Antiviral Drugs Market: By Indication , 2022
- Figure 15 Middle East And Africa Antiviral Drugs Market: By Indication , 2023-2030 (Usd Million)
- Figure 16 Middle East And Africa Antiviral Drugs Market: By Indication , Cagr (2023-2030)
- Figure 17 Middle East And Africa Antiviral Drugs Market: By Indication , Lifeline Curve
- Figure 18 Middle East And Africa Antiviral Drugs Market: By Patient Type, 2022
- Figure 19 Middle East And Africa Antiviral Drugs Market: By Patient Type, 2023-2030 (Usd Million)
- Figure 20 Middle East And Africa Antiviral Drugs Market: By Patient Type, Cagr (2023-2030)
- Figure 21 Middle East And Africa Antiviral Drugs Market: By Patient Type, Lifeline Curve
- Figure 22 Middle East And Africa Antiviral Drugs Market: By Product, 2022
- Figure 23 Middle East And Africa Antiviral Drugs Market: By Product, 2023-2030 (Usd Million)
- Figure 24 Middle East And Africa Antiviral Drugs Market: By Product, Cagr (2023-2030)
- Figure 25 Middle East And Africa Antiviral Drugs Market: By Product, Lifeline Curve
- Figure 26 Middle East And Africa Antiviral Drugs Market: By Drug Type, 2022
- Figure 27 Middle East And Africa Antiviral Drugs Market: By Drug Type, 2023-2030 (Usd Million)
- Figure 28 Middle East And Africa Antiviral Drugs Market: By Drug Type, Cagr (2023-2030)
- Figure 29 Middle East And Africa Antiviral Drugs Market: By Drug Type, Lifeline Curve
- Figure 30 Middle East And Africa Antiviral Drugs Market: By End User, 2022
- Figure 31 Middle East And Africa Antiviral Drugs Market: By End User, 2023-2030 (Usd Million)
- Figure 32 Middle East And Africa Antiviral Drugs Market: By End User, Cagr (2023-2030)
- Figure 33 Middle East And Africa Antiviral Drugs Market: By End User, Lifeline Curve
- Figure 34 Middle East And Africa Antiviral Drugs Market: By Distribution Channel, 2022
- Figure 35 Middle East And Africa Antiviral Drugs Market: By Distribution Channel, 2023-2030 (Usd Million)
- Figure 36 Middle East And Africa Antiviral Drugs Market: By Distribution Channel, Cagr (2023-2030)
- Figure 37 Middle East And Africa Antiviral Drugs Market: By Distribution Channel, Lifeline Curve
- Figure 38 Middle East And Africa Antiviral Drugs Market: Snapshot (2022)
- Figure 39 Middle East And Africa Antiviral Drugs Market: By Country (2022)
- Figure 40 Middle East And Africa Antiviral Drugs Market: By Country (2023 & 2030)
- Figure 41 Middle East And Africa Antiviral Drugs Market: By Country (2022 & 2030)
- Figure 42 Middle East And Africa Antiviral Drugs Market: Indication (2023-2030)
- Figure 43 Middle East And Africa Antiviral Drugs Market: Company Share 2022 (%) 250
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook